eISSN: 2449-8238
ISSN: 2392-1099
Clinical and Experimental Hepatology
Current issue Archive Manuscripts accepted About the journal Editorial board Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
Share:
Send email
Share:
Original paper

Telemedicine in the tertiary liver unit: A feasibility study

Daniel J. Havaj
1
,
Svetlana Adamcová-Selčanová
1
,
Klaudia Mesíková
2
,
Janka Vnenčáková
1
,
Daniela Žilinčanová
1
,
Natália Kubánek
1
,
Karolína K. Šulejová
1
,
Zuzana Mesárošová
1
,
Juraj Šváč
1
,
Radovan Lapuník
3
,
Viktória Ďurajová
2
,
Ľubomír Skladaný
1

  1. 2nd Department of Internal Medicine of the Slovak Medical University Faculty of Medicine, HEGITO (Div Hepatology, Gastroenterology, and Liver Transplant), F. D. Roosevelt Teaching Hospital, Banská Bystrica, Slovakia
  2. Office of Biomedical Research, F. D. Roosevelt Teaching Hospital, Banská Bystrica, Slovakia
  3. Department of Public Economics and Regional Development, Faculty of Economics, Matej Bel University in Banská Bystrica, Slovakia
Clin Exp HEPATOL 2024; 10, 4:
DOI: https://doi.org/10.5114/ceh.2024.145492
Online publish date: 2024/12/12
Article file
- 00688 - Telemedicine.pdf  [0.13 MB]
Get citation
 
PlumX metrics:
 
1. GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 2020; 5: 30349-8.
2. NCZI. 2020 Zdravotnícka ročenka SR. Bratislava 2021.
3. Arrese M. Telemedicine, COVID-19 and liver diseases: Revamping remote care initiatives in hepatology. Ann Hepatol 2020; 19: 339-340.
4. Serper M, Cubell AW, Deleener ME, et al. Telemedicine in liver disease and beyond: can the COVID-19 crisis lead to action? Hepatology 2020; 72: 723-728.
5. Tapper EB, Asrani SK. The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care. J Hepatol 2020; 73: 441-445.
6. Skladaný Ľ, Vnenčáková J, Havaj DJ, et al. Poster Abstracts: Increased mortality and decreased registrations in cirrhosis registry during COVID-19 eraers. Hepatology 2020; 72: 131A-1159A.
7. Skladaný L, Jancekova D, Bystrianska N, et al. Poster abstracts: Time-to tertiary care predicts mortality in alcohol-associated hepatitis in patients with cirrhosis. Hepatology 2021; 74: 157-1288.
8. Havaj DJ, Adamcová-Selčanová S, Žilinčanová D, et al. Telemedicine in hepatology – promising solution for our patients? Gastroenterol Hepatol 2023; 77: 130-135.
9. World Health Organization. Implementing telemedicine services during COVID-19: guiding principles and considerations for a stepwise approach. 2020 Nov.
10. World Health Organization. Global strategy on digital health 2020-2025. Geneva 2021.
11. Piao C, Terrault NA, Sarkar S. Telemedicine: An evolving field in hepatology. Hepatol Commun 2019; 3: 716-721.
12. World Health Organization. Telemedicine: opportunities and developments in Member States: report on the second global survey on eHealth 2009.
13. Fung BM, Perumpail M, Patel YA, Tabibian JH. Telemedicine in hepatology: Current applications and future directions. Liver Transpl 2022; 28: 294-303.
14. Capuano P, Hileman B, Tigano S, et al. Telemedicine in patients affected by chronic liver disease: A scoping review of clinical outcomes and the devices evaluated. J Clin Med 2023; 12: 5128.
15. Arora S, Kalishman S, Thornton K, et al. Expanding access to hepatitis C virus treatment – Extension for Community Healthcare Outcomes (ECHO) project: disruptive innovation in specialty care. Hepatology 2010; 52: 1124-1133.
16. Arora S, Thornton K, Murata G, et al. Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med 2011; 364: 2199-1207.
17. Rossaro L, Aoki C, Yuk J, et al. The evaluation of patients with hepatitis C living in rural California via telemedicine. Telemed J E Health 2008; 14: 1127-1129.
18. Beste LA, Glorioso TJ, Ho PM, et al. Telemedicine specialty support promotes hepatitis C treatment by primary care providers in the department of veterans affairs. Am J Med 2017; 130: 432-438.e3.
19. Rattay T, Dumont IP, Heinzow HS, Hutton DW. Cost-effectiveness of access expansion to treatment of hepatitis C virus infection through primary care providers. Gastroenterology 2017; 153: 1531-1543.e2.
20. Cooper CL, Hatashita H, Corsi DJ, et al. Direct-acting antiviral therapy outcomes in Canadian chronic hepatitis C telemedicine patients. Ann Hepatol 2017; 16: 874-880.
21. Tsertsvadze T, Gamkrelidze A, Chkhartishvili N, et al. Three years of progress toward achieving hepatitis C elimination in the country of Georgia, April 2015-March 2018. Clin Infect Dis 2020; 71: 1263-1268.
22. Choi DT, Sada YH, Sansgiry S, et al. Using telemedicine to facilitate patient communication and treatment decision-making following multidisciplinary tumor board review for patients with hepatocellular carcinoma. J Gastrointest Cancer 2023; 54: 623-631.
23. John BV, Love E, Dahman B, et al. Use of telehealth expedites evaluation and listing of patients referred for liver transplantation. Clin Gastroenterol Hepatol 2020; 18: 1822-1830.e4.
24. John BV, Love E, Dahman B, et al. Use of telehealth expedites evaluation and listing of patients referred for liver transplantation. Clin Gastroenterol Hepatol 2020; 18: 1822-1830.e4.
25. Konjeti VR, Heuman D, Bajaj JS, et al. Telehealth-based evaluation identifies patients who are not candidates for liver transplantation. Clin Gastroenterol Hepatol 2019; 17: 207-209.e1.
26. Ertel AE, Kaiser T, Shah SA. Using telehealth to enable patient-centered care for liver transplantation. JAMA Surg 2015; 150: 674-675.
27. Lee TC, Kaiser TE, Alloway A, et al. Telemedicine based remote home monitoring after liver transplantation: Results of a randomized prospective trial. Ann Surg 2019; 270: 564-572.
28. Rao BB, Sobotka A, Lopez R, et al. Outpatient telephonic transitional care after hospital discharge improves survival in cirrhotic patients. World J Hepatol 2019; 11: 646-655.
29. Nazareth S, Kontorinis N, Muwanwella N, et al. Successful treatment of patients with hepatitis C in rural and remote Western Australia via telehealth. J Telemed Telecare 2013; 19: 101-106.
30. Chen WL, Chiu WT, Wu MS, et al. Translational research of telecare for the treatment of hepatitis C. Biomed Res Int 2014; 2014: 195097.
31. Thygesen GB, Andersen H, Damsgaard BS, Sorknaes AD. The effect of nurse performed telemedical video consultations for patients suffering from alcohol-related liver cirrhosis. J Hepatol 2017; 66: S349.
32. Ganapathy D, Acharya C, Lachar J, et al. The patient buddy app can potentially prevent hepatic encephalopathy-related readmissions. Liver Int 2017; 37: 1843-1851.
33. Rosenblatt R, Yeh J, Gaglio PJ. Long-term management: modern measures to prevent readmission in patients with hepatic encephalopathy. Clin Liver Dis 2020; 24: 277-290.
34. Bloom P, Wang T, Marx M, et al. A smartphone app to manage cirrhotic ascites among outpatients: Feasibility study. JMIR Med Inform 2020; 8: e17770.
35. Nachman D, Gilan A, Goldstein N, et al. Twenty-four-hour ambulatory blood pressure measurement using a novel noninvasive, cuffless, wireless device. Am J Hypertens 2021; 34: 1171-1180.
36. Torous J, Staples P, Onnela JP. Realizing the potential of mobile mental health: new methods for new data in psychiatry. Curr Psychiatry Rep 2015; 17: 602.
37. Ertel AE, Kaiser T, Shah SA. Using telehealth to enable patient-centered care for liver transplantation. JAMA Surg 2015; 150: 674-675.
38. Khungar V, Serper M, Peyton D, et al. Use of an innovative telehealth platform to reduce readmissions and enable patient-centered care in cirrhotic patients. Hepatology 2017; 66: 94-95.
39. Thomson M, Volk M, Kim HM, et al. An automated telephone monitoring system to identify patients with cirrhosis at risk of re-hospitalization. Dig Dis Sci 2015; 60: 3563-3569.
40. Mauro E, Marciano S, Torres MC, et al. Telemedicine improves access to hepatology consultation with high patient satisfaction. J Clin Exp Hepatol 2020; 10: 555-562.
41. Smets E, Rios Velazquez E, Schiavone G, et al. Large-scale wearable data reveal digital phenotypes for daily-life stress detection. NPJ Digit Med 2018; 1: 67.
42. Burns MN, Begale M, Duffecy J, et al. Harnessing context sensing to develop a mobile intervention for depression. J Med Internet Res 2011; 13: e55.
43. Skladaný Ľ, Líška D, Liptáková E, et al. Comparison of the quality of life of patients with liver cirrhosis before and during the COVID-19 lockdown in Slovakia. Sci Rep 2023; 13: 2463.
44. Fix OK, Serper M. Telemedicine and telehepatology during the COVID-19 pandemic. Clin Liver Dis (Hoboken) 2020; 15: 187-190.
45. Fix OK, Hameed B, Fontana RJ, et al. Clinical best practice advice for hepatology and liver transplant providers during the COVID-19 pandemic: AASLD Expert Panel Consensus Statement. Hepatology 2020; 72: 287-304.
46. Boettler T, Newsome PN, Mondelli MU, et al. Care of patients with liver disease during the COVID-19 pandemic: EASLESCMID position paper. JHEP Rep 2020; 2: 100113.
47. Klobusovska I, Belovicova M, Popovicova M, Hudakova T. Comparison of health literacy of the population regarding healthy diet and chronic liver diseases – West vs. East of Slovakia. Clinical Social Work and Health Intervention 2021; 12: 22-28.
48. Curtis ME, Clingan SE, Guo H, et al. Disparities in digital access among American rural and urban households and implications for telemedicine-based services. J Rural Health 2022; 38: 512-518.
49. Švecová M, Odlerová E. Smartphone and mobile application usage among seniors in Slovakia. Eur J Sci Theology 2018; 14: 125-133.
50. Wegermann K, Wilder JM, Parish A, et al. Racial and socioeconomic disparities in utilization of telehealth in patients with liver disease during COVID-19. Dig Dis Sci 2022; 67: 93-99.
51. Ho C, Serper M. Practical approach to starting a telemedicine program: Lessons from the real world. Clin Liver Dis (Hoboken) 2022; 19: 153-156.
52. Price JC, Simpson DC. Telemedicine and health disparities. Clin Liver Dis (Hoboken) 2022; 19: 144-147.
53. Bauer MS, Kirchner J. Implementation science: What is it and why should I care? Psychiatry Res 2020; 283: 112376.
54. Wu T, Simonetto DA, Halamka JD, Shah VH. The digital transformation of hepatology: The patient is logged in. Hepatology 2022; 75: 724-739.
55. Bloom PP, Robin J, Xu M, et al. Hepatic encephalopathy is associated with slow speech on objective assessment. Am J Gastroenterol 2021; 116: 1950-1953.
56. Lim SL, Johal J, Ong KW, et al. Lifestyle intervention enabled by mobile technology on weight loss in patients with nonalcoholic fatty liver disease: Randomized controlled trial. JMIR Mhealth Uhealth 2020; 8: e14802.
57. Duarte-Rojo A, Bloomer PM, Rogers RJ, et al. Introducing EL-FIT (Exercise and Liver FITness): A smartphone app to prehabilitate and monitor liver transplant candidates. Liver Transpl 2021; 27: 502-512.
58. Kruse CS, Lee K, Watson JB, et al. Measures of effectiveness, efficiency, and quality of telemedicine in the management of alcohol abuse, addiction, and rehabilitation: Systematic review. J Med Internet Res 2020; 22: e13252.
59. Lieber SR, Kim HP, Baldelli L, et al. What liver transplant recipients want in a smartphone intervention to enhance recovery: Prototype for the LiveRight Transplant App. Liver Transplantation 2021; 27: 584-589.
60. Agha Z, Schapira RM, Laud PW, et al. Patient satisfaction with physician-patient communication during telemedicine. Telemed J E Health 2009; 15: 830-839.
61. Elliott T, Tong I, Sheridan A, Lown BA. Beyond convenience: Patients’ perceptions of physician interactional skills and compassion via telemedicine. Mayo Clin Proc Innov Qual Outcomes 2020; 4: 305-314.
62. Le LB, Rahal HK, Viramontes MR, et al. Patient satisfaction and healthcare utilization using telemedicine in liver transplant recipients. Dig Dis Sci 2019; 64: 1150-1157.
63. Louissaint J, Lok AS, Fortune BE, Tapper EB. Acceptance and use of a smartphone application in cirrhosis. Liver Int 2020; 40: 1556-1563.
64. Acharya C, Sehrawat TS, McGuire DB, et al. Perspectives of inpatients with cirrhosis and caregivers on using health information technology: Cross-sectional multicenter study. J Med Internet Res 2021; 23: e24639.
65. Franc S, Joubert M, Daoudi A, et al. Efficacy of two telemonitoring systems to improve glycaemic control during basal insulin initiation in patients with type 2 diabetes: The TeleDiab-2 randomized controlled trial. Diabetes Obes Metab 2019; 21: 2327-2332.
66. Warren R, Carlisle K, Mihala G, Scuffham PA. Effects of telemonitoring on glycaemic control and healthcare costs in type 2 diabetes: A randomised controlled trial. J Telemed Telecare 2018; 24: 586-595.
67. Margolis KL, Asche SE, Dehmer SP, et al. Long-term outcomes of the effects of home blood pressure telemonitoring and pharmacist management on blood pressure among adults with uncontrolled hypertension: Follow-up of a cluster randomized clinical trial. JAMA Netw Open 2018; 1: e181617.
68. Bloom PP, Ventoso M, Tapper E, et al. A telemonitoring intervention for cirrhotic ascites management is cost-saving. Dig Dis Sci 2022; 67: 854-862.
Copyright: © Clinical and Experimental Hepatology. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/) enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.